Demystifying NPM1 in AML: What It Means and Why It Matters image

Demystifying NPM1 in AML: What It Means and Why It Matters

Jul 02, 2025
04:00PM - 05:00PM EDT
Online Event
Overview

Join us for the next session in our AML genetics series as we explore the NPM1 mutation—one of the most common genetic changes found in acute myeloid leukemia (AML). Dr. Shai Shimony, a physician in Medical Oncology at Dana-Farber Cancer Institute, will walk us through what NPM1 is, how it impacts diagnosis and treatment decisions, and why it’s important in understanding your specific type of AML. Whether you’re newly diagnosed or looking to understand your AML journey better, this session will help you feel more informed and confident when speaking with your care team.

Agenda
4:00 PM
Introduction
Mary Arnett

Mary introduces the agenda for the event and featured speaker Shai Shimony MD, MPH

4:05 PM
Presentation
Shai Shimony MD, MPH

Dr. Shimony talks about NPM1 in AML

4:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Mary Arnett

Mary Arnett

Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Healthtree contact Shai Shimony MD, MPH

Shai Shimony MD, MPH

Dr. Shai Shimony is a leukemia specialist with advanced training from Dana-Farber Cancer Institute and a Master’s in Clinical Effectiveness from Harvard. His clinical and research focus centers around improving care and outcomes for patients with acute leukemias, especially AML, ALL, and rare subtypes like BPDCN.